Literature DB >> 24236300

MicroRNA: A New Player for Cancer Chemoprevention.

Yaguang Xi1.   

Abstract

Entities:  

Keywords:  Chemoprevention; Metastasis; MicroRNA

Year:  2013        PMID: 24236300      PMCID: PMC3824393          DOI: 10.4172/2329-6771.1000105

Source DB:  PubMed          Journal:  J Integr Oncol


× No keyword cloud information.
  30 in total

Review 1.  The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

Authors:  Michelle A Carmell; Zhenyu Xuan; Michael Q Zhang; Gregory J Hannon
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

Review 2.  Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.

Authors:  S D Hursting; T J Slaga; S M Fischer; J DiGiovanni; J M Phang
Journal:  J Natl Cancer Inst       Date:  1999-02-03       Impact factor: 13.506

3.  Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation.

Authors:  Yong Sun Lee; Hak Kyun Kim; Sangmi Chung; Kwang-Soo Kim; Anindya Dutta
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

Review 4.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

5.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Authors:  Yoko Karube; Hisaaki Tanaka; Hirotaka Osada; Shuta Tomida; Yoshio Tatematsu; Kiyoshi Yanagisawa; Yasushi Yatabe; Junichi Takamizawa; Shinichiro Miyoshi; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Sci       Date:  2005-02       Impact factor: 6.716

6.  Sulindac suppresses tumorigenesis in the Min mouse.

Authors:  Y Beazer-Barclay; D B Levy; A R Moser; W F Dove; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Carcinogenesis       Date:  1996-08       Impact factor: 4.944

7.  The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.

Authors:  N N Mahmoud; S K Boolbol; A J Dannenberg; J R Mestre; R T Bilinski; C Martucci; H L Newmark; A Chadburn; M M Bertagnolli
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

8.  A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.

Authors:  Jason D Whitt; Nan Li; Heather N Tinsley; Xi Chen; Wei Zhang; Yonghe Li; Bernard D Gary; Adam B Keeton; Yaguang Xi; Ashraf H Abadi; William E Grizzle; Gary A Piazza
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

9.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

10.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

View more
  3 in total

1.  Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.

Authors:  Ruixia Ma; Bin Yi; Gary A Piazza; Yaguang Xi
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

2.  Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy.

Authors:  Bin Yi; Hao Cheng; Dorota Wyczechowska; Qingzhao Yu; Li Li; Augusto C Ochoa; Adam I Riker; Yaguang Xi
Journal:  Mol Cancer Ther       Date:  2021-04-20       Impact factor: 6.261

3.  miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.

Authors:  Wei Lu; Yunping Hu; Qiang Ma; Linzhu Zhou; Lin Jiang; Zhizhen Li; Shuai Zhao; Yuzhen Xu; Weibin Shi; Sheng Li; Yingbin Liu
Journal:  Oncotarget       Date:  2016-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.